Essex Bio-Technology Adds 8,000 Shares to Treasury via HK$0.02 Million Buyback on 9 Oct 2026

Bulletin Express10-09

Essex Bio-Technology Limited repurchased 8,000 ordinary shares on 9 October 2026 through on-market transactions at an average price of HK$2.0788 per share, within a high/low range of HK$2.085–2.075. The aggregate consideration totalled HK$0.02 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) decreased marginally by 0.00142 % to 564.82 million shares, while treasury shares rose to 2.18 million. The total number of issued shares remained unchanged at 567.01 million because the repurchased shares have been retained in treasury and not cancelled.

The buyback forms part of the mandate approved by shareholders on 26 May 2026, which authorises Essex Bio-Technology to repurchase up to 56.70 million shares. Cumulative repurchases under this mandate now stand at 2.18 million shares, representing 0.39 % of the share base at the time the authority was granted, leaving 54.52 million shares available for further repurchase.

In line with Hong Kong listing regulations, the company is restricted from issuing new shares or disposing of treasury shares until 8 November 2026, 30 days after the latest repurchase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment